This 3 minute video introduces Nivolumab, a groundbreaking immunotherapy recently offered by the NHS in the UK as of spring 2025. Nivolumab is an immune checkpoint inhibitor, and represents a major advancement in cancer treatments that help the body’s own immune system to fight cancer. While the public is generally familiar with traditional treatments like chemotherapy, radiation, and surgery, immunotherapy remains a relatively new and unfamiliar concept, making accessible educational resources like this especially important.

Targeted at the general public and introductory medical students, this animation simplifies complex scientific concepts to clearly explain how Nivolumab works and why it matters. By making cutting-edge science engaging and understandable, this project aims to increase public health literacy, promote awareness of immunotherapy, and build trust in innovative cancer treatments. For students, it offers a strong foundation in immune-based therapies, supporting early clinical education. On a broader scale, as immunotherapy becomes a cornerstone of global cancer care, this video contributes to bridging the gap between medical advancement and community understanding.